Goldman Sachs Leads $62M Series D Round In Chinese CRO Firm Fountain Medical

Fountain Medical, a Chinese clinical-stage contract research organization (CRO) offering one-stop services to pharmaceutical and medical device companies, has raised US$62 million in a series D round of financing led by global investment bank Goldman Sachs. Shanghai-based healthcare-focused venture capital firm Lilly Asia Ventures also participated in this round, according to a statement released by […]

Goldman Sachs Leads $62M Series D Round In Chinese CRO Firm Fountain Medical comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network